These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1894382)

  • 21. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system.
    Sato H; Sato Y
    Infect Immun; 1984 Nov; 46(2):415-21. PubMed ID: 6542069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of human monoclonal antibodies that confer protection against pertussis toxin.
    Zaccolo M; Roggero S; Armellini D; Pegoraro L; Rappuoli R; Malavasi F
    Infect Immun; 1992 Mar; 60(3):1258-60. PubMed ID: 1541543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody that neutralizes pertussis toxin activities.
    Pootong A; Budhirakkul P; Tongtawe P; Tapchaisri P; Chongsa-nguan M; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):37-45. PubMed ID: 17891920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of murine monoclonal antibodies that recognize defined epitopes of pertussis toxin and neutralize its toxic effect on Chinese hamster ovary cells.
    Walker MJ; Wehland J; Timmis KN; Raupach B; Schmidt MA
    Infect Immun; 1991 Nov; 59(11):4249-51. PubMed ID: 1718872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
    Boucher P; Sato H; Sato Y; Locht C
    Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sensitive method for measuring neutralizing antibodies to Bordetella pertussis toxin: optimized ADP-ribosylation of transducin.
    Magnusson R; Larsson U; Bartfai T; Askelöf P
    Biologicals; 1991 Jan; 19(1):9-15. PubMed ID: 2049177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope specificity of three anti-pertussis toxin monoclonal antibodies with dissimilar effects in assays of toxin neutralizing activity.
    Halperin SA; Issekutz TB; Kasina A
    Mol Immunol; 1991 Mar; 28(3):247-50. PubMed ID: 1708105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction between pertussis toxin and 10 monoclonal antibodies.
    Schou C; Au-Jensen M; Heron I
    Acta Pathol Microbiol Immunol Scand C; 1987 Oct; 95(5):177-87. PubMed ID: 2447745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of Pertussis toxin subunits.
    Sheu GC; Wo YY; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):182-93. PubMed ID: 10592823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
    Barbieri JT; Armellini D; Molkentin J; Rappuoli R
    Infect Immun; 1992 Dec; 60(12):5071-7. PubMed ID: 1452339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model.
    Olander RM; Muotiala A; Karvonen M; Kuronen T; Runeberg-Nyman K
    Microb Pathog; 1990 Jan; 8(1):37-45. PubMed ID: 2159104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
    Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
    Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Humoral response to the injection of acellular Pertussis vaccine].
    Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
    Taranger J; Trollfors B; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    J Infect Dis; 2000 Mar; 181(3):1010-3. PubMed ID: 10720524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
    BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pertussis whole cell vaccine: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin and adenylate cyclase.
    Dellepiane NI; Manghi MA; Eriksson PV; di Paola G; Cangelosi A
    Zentralbl Bakteriol; 1992 Jun; 277(1):65-73. PubMed ID: 1520970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
    Zackrisson G; Taranger J; Trollfors B
    J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
    Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.